GateBioscience
gatebio.com
Actively hiring
Drug Discovery
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
ARCH Venture Partners
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
ARCH Venture Partners Similar startupsby what they do, their industry and backers
Light Horse is a small molecule drug discovery company that is leading the way in a.
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
AI-first biotech accelerating early drug discovery with protein–ligand insights and advanced models for molecular understanding. Khumbu.ai.
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Overview
Gate Bioscience is developing Molecular Gates, a new frontier in protein elimination. Molecular Gates are small molecule drugs that selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease.